SPDR S&P Biotech ETF (NYSEARCA:XBI) Position Boosted by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 74.7% in the third quarter, Holdings Channel.com reports. The firm owned 4,002 shares of the exchange traded fund’s stock after acquiring an additional 1,711 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $395,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in XBI. ORG Partners LLC purchased a new stake in SPDR S&P Biotech ETF in the 2nd quarter worth approximately $40,000. ORG Wealth Partners LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth $44,000. Resources Management Corp CT ADV boosted its position in SPDR S&P Biotech ETF by 30.3% during the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock valued at $55,000 after purchasing an additional 138 shares during the last quarter. Lynx Investment Advisory purchased a new position in SPDR S&P Biotech ETF in the second quarter valued at about $58,000. Finally, GPS Wealth Strategies Group LLC increased its position in SPDR S&P Biotech ETF by 35.9% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 674 shares of the exchange traded fund’s stock worth $63,000 after purchasing an additional 178 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI opened at $97.15 on Monday. The business has a 50-day moving average of $99.14 and a 200-day moving average of $94.65. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The company has a market capitalization of $7.40 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.